MedTrace Logo

Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department

NCT03256487 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2017-10-19

No results posted yet for this study

Summary

This study evaluates intravenous (IV) buprenorphine versus IV morphine for the management of severe, acute pain among emergency department (ED) patients. ED patients with severe pain will be randomized in equal proportion to receive IV buprenorphine or IV morphine.

Conditions

Interventions

DRUG

Buprenorphine

buprenorphine 0.3mg IV

DRUG

Morphine Sulfate

morphine 0.1 mg/kg IV (max 8mg per dose)

Sponsors & Collaborators

  • Alameda Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-26
Primary Completion
2018-02-01
Completion
2018-07-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03256487 on ClinicalTrials.gov